Skip to main content

Sarcopenia in Elderly

1
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

TNF Pharmaceuticals
TNF PharmaceuticalsMD - Baltimore
1 program
1
Isomyosamine 250mgPhase 21 trial
Active Trials
NCT06942182Not Yet Recruiting60Est. Mar 2026
Coordination Pharmaceuticals
1 program
Blood Flow RestrictionN/A1 trial
Active Trials
NCT07689487Completed31Est. Jun 2026
Innovation Pharmaceuticals
1 program
MediDrink Platinum+N/A1 trial
Active Trials
NCT07322653Recruiting75Est. Jan 2027

Trial Timeline

Clinical trial activity over time

2025
2026
2027
TNF PharmaceuticalsIsomyosamine 250mg
Coordination PharmaceuticalsBlood Flow Restriction
Innovation PharmaceuticalsMediDrink Platinum+

Clinical Trials (3)

Total enrollment: 166 patients across 3 trials

NCT06942182TNF PharmaceuticalsIsomyosamine 250mg

Safety and Efficacy of Isomyosamine in Reducing Inflammation and Treating Muscle Loss in Older Adults After Hip or Thigh Bone Fractures

Start: May 2025Est. completion: Mar 202660 patients
Phase 2Not Yet Recruiting
NCT07689487Coordination PharmaceuticalsBlood Flow Restriction

Effects of Cyclical Blood Flow Restriction Exercise on Muscle Hypertrophy and Capillaries in Older Adults

Start: Feb 2026Est. completion: Jun 202631 patients
N/ACompleted
NCT07322653Innovation PharmaceuticalsMediDrink Platinum+

The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population

Start: Sep 2025Est. completion: Jan 202775 patients
N/ARecruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 166 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.